Antimicrobial TSifran. Uluwehi O'Āpana

Medicine "TSifran" mea he antimicrobial Agena me ka palahalaha pae o ka hana a me ka pili ana i ka pharmacological pae o fluoroquinolones. Hana eiiiiiaiou o ka lāʻau mea ciprofloxacin a me ka tinidazole. Ma muli o ka suppression o ka DNA gyrase a me ka mea koʻohune DNA hoʻololi kemikala inhibition, i kēia mau hana waiwai i mahalo hana no ka hapanui gram-io microorganisms.

Ma 'ana, i ka ha awina o ka bactericidal hana o ka la hoomalolo "TSifran" manual memo me ka pili ana i kēia mau koʻohune: Neisseriagonorrhoeae, Neisseriameningitidis, Haemophilusinfluenzae, Pseudomonasaeruginosa, Salmonellaspp, Escherichiacoli a me nā microorganisms ke kanana nei ka hana a me ka ole ka hana penicillinase, e like me methicillin-hoʻopale ke kanana nei a me Enterococcusspp, Chlamydiaspp, Mycobacteriumspp, Legionellaspp ... ke kanana nei.

Pharmacological hana o bactericidal medicament palahalaha pae "TSifran" kauoha no ka hoʻohana mea like penei: ". Ka mea paahana ua manao ia no ka iapaau ana o infectious pathologies ka pono ma ka iapaau ana o ka hoʻoʻino keʻano o ka hanaʻana - hui nā mea palahēhē hoʻonāukiuki aku ma ka ha awina o aerobic a me ka anaerobic microorganisms a me protozoa".

Pharmacokinetics

Ke hana nā mea hoʻohui o ka lāʻau "TSifran" kauoha no ka hoʻohana pili ia i mahalo hana maʻalahi. A me ka ciprofloxacin a me tinidazole i maikai omo i loko o ka gastrointestinal'āpana.

E noonoo pono i kela mea keia mea o ka hana nā mea hoʻohui o ka lāʻau, ka mea e e kaulana ia ciprofloxacin loaʻa ma kahi o 70% bioavailability. Kona omo ua ka meheu iki, oiai ka hoʻohana o ka meaʻai. Kēia lāʻau, he maikai permeability i loko o nā'aʻaʻa a me ke kino fluids, a me ka iwi, Muscle, momona, a me ka cartilage'aʻaʻa. He komo i loko o nā loko o ka urinary'ōnaehana, a me loko o ke kino e like me ka prostate. Ua ua he malu ka mea hōʻike he kiʻekiʻe lehulehu maʻiʻo kiprofloksatsina, e like me ka, oiaio, a ma ka semen, tuha, bile, lymph loli, mucus.

Tinidazole okoa loa bioavailability. Kēia ke keʻena i haule koke ma kiʻekiʻe nā hoʻohui like ma'aʻaʻa o ke kanaka kino wai meakino komo iloko, i ka maikai ma ka cerebrospinal loli, i ua kiaʻana i kāna i loko o ka ia me ia ma ka wai kokoʻilikai. About ka hapaha o ke dala o ke kino waiwai excreted i loko o ka mimi kŰlń, ua hoʻokuʻuʻia ma kahi o 10% i loko o ka palapala o metabolites, he uuku hapa o ka ke keʻena koe i ke kino i loko o ka faeces.

Nāʻikepili no ka lāʻau "TSifran" kauoha no ka hoʻohana pili ana i ka hui hana o infectious keʻano o ka hanaʻana. Mawaena o ka hou kekahi pathologies, no ka iapaau ana o ka lāʻau ma lalo o ka noonoo i ua hoʻohana 'ia, i ka i kēia maʻi.

• maʻi osteomyelitis ;

• ke kūʻai '-infectious hoʻoʻino keʻano o ka hanaʻana;

• amoebic ka hī koko, a me ka hi koko i hui type (amoebic a me ka mea koʻohune);

• periodontitis, periostitis a me nā infectious maʻi o ka moʻolelo o ka lua;

• gynecological hoʻoʻino pathology;

• maʻi sinusitis;

• nā mea palahēhē o ka ili a me ka pahee nā'aʻaʻa;

• postoperative infectious maʻi;

• akemāmā abscess.

Kekahi o ia mau mea, a me nā nā mea palahēhē, kena ae la ia e aerobic a me ka anaerobic koʻohune ikepili koʻikoʻi i ka hana ana i ka lāʻau 'eiiiiiaiou.

Maliuia mai ko lakou hoomakaukau ana "TSifran" postprandial. E e ia papa me ka wai i loko o ua lawa na mea. Kanaka makua hoʻomanawanui iki mai e lawe i ka lāʻau,ʻelua hahauʻana i ka lā i ka papa o ka 500 / 600mg a mau 250 / 300mg. Hoʻomanawanui iki mai ma lalo o ka makahiki o ka umikumamawalu makahiki o ka makahiki, i ka lāʻau 'ua i lawelawe. Ua UaʻAʻole pono no ka lawe ana ma hapai.

Contraindications i ka hoʻohana 'ana i ka mea i ho'ākāka' ia i loko o ka lāʻau 'Inc o ka loa pā lonoaʻili i ka eiiiiiaiou ho okumu i kekahi hapa o ka tsifran a me ka pathology o ke koko, porphyria.